Non-Current Assets
Other Non-Current Assets
Eli Lilly Other Non-Current Assets increased by 3.4% to $7.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.0%, from $6.07B to $7.23B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 15.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Significant changes may indicate shifts in long-term operational strategy or changes in accounting for specific non-core assets.
Detailed definition
This captures miscellaneous long-term assets that do not fit into specific categories like property, plant, equipment, o...
Peer comparison
Varies widely by company; usually represents a small percentage of total assets.
Metric ID:
non_current_assets_other_assets_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.64B | $3.71B | $4.08B | $4.29B | $4.47B | $4.54B | $4.34B | $4.49B | $4.67B | $4.91B | $4.99B | $4.71B | $4.90B | $5.12B | $5.72B | $6.07B | $6.23B | $6.43B | $6.99B | $7.23B |
| QoQ Change | — | +2.0% | +10.0% | +5.0% | +4.3% | +1.4% | -4.4% | +3.5% | +4.1% | +5.1% | +1.6% | -5.6% | +4.2% | +4.4% | +11.7% | +6.2% | +2.5% | +3.3% | +8.7% | +3.4% |
| YoY Change | — | — | — | — | +22.9% | +22.2% | +6.2% | +4.7% | +4.5% | +8.3% | +15.1% | +4.9% | +5.0% | +4.3% | +14.6% | +29.0% | +26.9% | +25.6% | +22.2% | +19.0% |
Range$3.64B – $7.23B
CAGR+15.6%
Avg YoY Growth+14.7%
Median YoY Growth+14.8%
Current Streak8 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other non-current assets?
- Eli Lilly (LLY) reported other non-current assets of $7.23B in Q1 2026.
- How has Eli Lilly's other non-current assets changed year-over-year?
- Eli Lilly's other non-current assets increased by 19.0% year-over-year, from $6.07B to $7.23B.
- What is the long-term trend for Eli Lilly's other non-current assets?
- Over 5 years (2020 to 2025), Eli Lilly's other non-current assets has grown at a 15.0% compound annual growth rate (CAGR), from $3.48B to $6.99B.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into standard reporting categories.